| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Authors’ Reply to Yusuf Ziya Sener: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”
|
Kim, Jwa Hoon
|
|
|
15 |
3 |
p. 413-414
|
artikel
|
| 2 |
Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis
|
Chen, Ya
|
|
|
15 |
3 |
p. 337-345
|
artikel
|
| 3 |
Comment on: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”
|
Şener, Yusuf Ziya
|
|
|
15 |
3 |
p. 411
|
artikel
|
| 4 |
Co-Regulation of Immune Checkpoint PD-L1 with Interferon-Gamma Signaling is Associated with a Survival Benefit in Renal Cell Cancer
|
Hänze, Jörg
|
|
|
15 |
3 |
p. 377-390
|
artikel
|
| 5 |
Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors
|
Formica, Vincenzo
|
|
|
15 |
3 |
p. 327-336
|
artikel
|
| 6 |
Heterogeneous Response to First-Generation Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancers with Different EGFR Exon 19 Mutations
|
Xu, Haiyan
|
|
|
15 |
3 |
p. 357-364
|
artikel
|
| 7 |
Impact of Serum γ-Glutamyltransferase on Overall Survival in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
|
Takemura, Kosuke
|
|
|
15 |
3 |
p. 347-356
|
artikel
|
| 8 |
Impact of the COVID-19 Outbreak on the Management of Patients with Cancer
|
Raymond, Eric
|
|
|
15 |
3 |
p. 249-259
|
artikel
|
| 9 |
Impact of the Neutrophil-to-Lymphocyte Ratio on the Survival of Patients with Gastric Cancer Treated with Nivolumab Monotherapy
|
Yamada, Takanobu
|
|
|
15 |
3 |
p. 317-325
|
artikel
|
| 10 |
Management of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance
|
Lorusso, Domenica
|
|
|
15 |
3 |
p. 391-406
|
artikel
|
| 11 |
MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside
|
Ratti, Margherita
|
|
|
15 |
3 |
p. 261-278
|
artikel
|
| 12 |
Molecular Targeting of a BRAF Mutation in Pancreatic Ductal Adenocarcinoma: Case Report and Literature Review
|
Seghers, An-Katrien
|
|
|
15 |
3 |
p. 407-410
|
artikel
|
| 13 |
Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry
|
Chowdhury, Simon
|
|
|
15 |
3 |
p. 301-315
|
artikel
|
| 14 |
Targeting CD79b for Chimeric Antigen Receptor T-Cell Therapy of B-Cell Lymphomas
|
Ding, Shengnan
|
|
|
15 |
3 |
p. 365-375
|
artikel
|
| 15 |
Utilisation and Determinants of Epidermal Growth Factor Receptor Mutation Testing in Patients with Non-small Cell Lung Cancer in Routine Clinical Practice: A Global Systematic Review
|
Thi, Aye Myat
|
|
|
15 |
3 |
p. 279-299
|
artikel
|
Tijdschrift beschrijving